Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PercuSurge Committed To Boston Scientific Carotid Stent Trial

This article was originally published in The Gray Sheet

Executive Summary

PercuSurge will proceed with plans to conduct U.S. trials of its GuardWire distal protection device with Boston Scientific's WallStent for carotid angioplasty, in spite of rival Medtronic's proposed purchase of the company for $225 mil., announced Oct. 19.
Advertisement

Related Content

Boston Scientific Carotid Stent 2004 Launch Will Court Vascular Surgeons
Boston Scientific Carotid Stent 2004 Launch Will Court Vascular Surgeons
Medtronic GuardWire Begins Controlled Roll-Out In U.S. Market
Medtronic GuardWire Begins Controlled Roll-Out In U.S. Market
Boston Scientific Gains Distal Protection Market Entry With EPI's Filterwire
Abbott Entering Embolic Protection, Carotid Stent Markets Via MedNova
MedNova Hopes To Bundle X.act Carotid Stent With NeuroShield
Boston Scientific Embol-X Buy Readies Firm For Carotid Stent Race
J&J AngioGuard Emboli Capture Device Purchase Portends SMART Bundle
J&J AngioGuard Emboli Capture Device Purchase Portends SMART Bundle
Advertisement
UsernamePublicRestriction

Register

MT014018

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel